Skip to main content

Table 4 Multivariate cox regression analysis of risk factors for ESBL-producing Enterobacteriaceae infection among kidney recipients depending on some variables

From: Perioperative prophylaxis with ertapenem reduced infections caused by extended-spectrum betalactamase-producting Enterobacteriaceae after kidney transplantation

Variable

ESLB-producing Enterobacteriaceae infection

HR (95%CI)

P

Yes

No

Age

 < 50 years

2 (17%)

 

0.5 (0.1–2.7)

0.5

 ≥ 50 years

10 (83%)

62 (60%)

Sex

 Male

2 (17%)

58 (56%)

0.16 (0.03–0.75)

0.02

 Female

10 (83%)

46 (44%)

Diabetes mellitus

 Yes

2 (17%)

80 (77%)

0.9 (1.6–5.7)

0.9

 No

10 (83%)

24 (23%)

Prior transplantation

 Yes

3 (25%)

86 (83%)

5.8 (1.2–30)

0.04

 No

9 (75%)

18 (17%)

Prophylaxis group

 Cefazolin

10 (83%)

53 (51%)

4.7 (1.1–22.6)

0.05

 Ertapenem

2 (17%)

51 (49%)

Acute allograft rejection

 Yes

1 (8%)

26 (25%)

14.5 (1.3–162)

0.03

 No

11 (92%)

78 (75%)

Post-transplant Haemodialysis

 Yes

3 (25%)

26 (25%)

0.3 (0.06–1.2)

0.09

 No

9 (75%)

78 (75%)

Nephrostomy

 Yes

1 (8%)

8 (8%)

0.8 (1.3–0.1)

0.8

 No

11 (92%)

96 (92%)

Reoperation

 Yes

3 (25%)

11 (11%)

2.6 (0.6–12)

0.2

 No

9 (75%)

93 (89%)